Media Summary: Regis' Director of Analytical Method Development, Dr. Paul Wrezel, repurposes his Pittcon 2015 talk for a Regis audience. This is ... Regis' Director of Analytical Method Development, Dr. Paul Wrezel, repurposes his Pittcon 2015 talk for a Regis audience. CDER's Office of Pharmaceutical Quality's Hongbio Liao and Office of Generic Drugs' Victoria Keck discuss
Selected Case Studies And Impurity - Detailed Analysis & Overview
Regis' Director of Analytical Method Development, Dr. Paul Wrezel, repurposes his Pittcon 2015 talk for a Regis audience. This is ... Regis' Director of Analytical Method Development, Dr. Paul Wrezel, repurposes his Pittcon 2015 talk for a Regis audience. CDER's Office of Pharmaceutical Quality's Hongbio Liao and Office of Generic Drugs' Victoria Keck discuss Yiwei Li from CDER's Office of Pharmaceutical Quality shares a Dr. Steven Baertschi delivered this talk in South San Francisco, CA on October 31, 2018. Development and implementation of ... I share the truths you need to know about
The need to identify and characterise unknown FDA discusses the OGD-Pharmacology/Toxicology (Pharm/Tox) process for safety evaluation of Many pharmaceutical companies struggle with characterizing drug substance (DS) and drug product (DP)
